ILO Home
  

ICSC index [List of Chemicals]  [Risk Notes]  [Risk Phrases]  [Safety Phrases]  [Danger Symbols] Bottom of page (Ctrl-End)
PIPERIDINE ICSC: 0317
November 2003
Hexahydropyridine
Azacyclohexane
Pentamethyleneimine
PDF for printing Explanation of fields
CAS No: 110-89-4
RTECS No: TM3500000
UN No: 2401
EC No: 613-027-00-3
    C5H11N / CH2(CH2)4NH
Molecular mass: 85.2

TYPES OF
HAZARD /
EXPOSURE
ACUTE HAZARDS / SYMPTOMS      PREVENTION         FIRE FIGHTING   
FIRE Highly flammable. NO open flames, NO sparks, and NO smoking. Powder, alcohol-resistant foam, water in large amounts, carbon dioxide.
EXPLOSION Vapour/air mixtures are explosive. Closed system, ventilation, explosion-proof electrical equipment and lighting. Do NOT use compressed air for filling, discharging, or handling. In case of fire: keep drums, etc., cool by spraying with water.
 
EXPOSURE   STRICT HYGIENE! IN ALL CASES CONSULT A DOCTOR!
Inhalation Burning sensation. Cough. Laboured breathing. Shortness of breath. Sore throat. Symptoms may be delayed (see Notes). Ventilation, local exhaust, or breathing protection. Fresh air, rest. Half-upright position. Artificial respiration may be needed. Refer for medical attention.
Skin MAY BE ABSORBED! Redness. Skin burns. Pain. Protective gloves. Protective clothing. Remove contaminated clothes. Rinse skin with plenty of water or shower. Refer for medical attention.
Eyes Redness. Pain. Blurred vision. Severe deep burns. Face shield, or eye protection in combination with breathing protection. First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then take to a doctor.
Ingestion Abdominal pain. Burning sensation. Laboured breathing. Shock or collapse. Do not eat, drink, or smoke during work. Rinse mouth. Do NOT induce vomiting. Give plenty of water to drink. Refer for medical attention.

SPILLAGE DISPOSAL PACKAGING & LABELLING
Collect leaking liquid in sealable containers. Absorb remaining liquid in sand or inert absorbent and remove to safe place. (Extra personal protection: self-contained breathing apparatus.) F Symbol
T Symbol
R: 11-23/24-34
S: (1/2-)16-26-27-45
UN Hazard Class: 8
UN Subsidiary Risks: 3
UN Pack Group: I


EMERGENCY RESPONSE STORAGE
Transport Emergency Card: TEC (R)-80GCF1-I
NFPA Code: H 3; F 3; R 3
Fireproof. Separated from strong oxidants, acids, and incompatible materials. See Chemical Dangers.

IMPORTANT DATA
Physical State; Appearance
COLOURLESS LIQUID, WITH CHARACTERISTIC ODOUR.

Physical dangers
The vapour is heavier than air and may travel along the ground; distant ignition possible.

Chemical dangers
The substance decomposes on burning producing toxic fumes including nitrogen oxides. The substance is a medium strong base. Reacts violently with oxidants. Reacts violently with dicyanofurazan, N-nitrosoacetanilide and 1-perchloryl-piperidine, causing explosion hazard.

Occupational exposure limits
TLV not established.

Routes of exposure
The substance can be absorbed into the body by inhalation of its vapour, through the skin and by ingestion.

Inhalation risk
No indication can be given about the rate in which a harmful concentration in the air is reached on evaporation of this substance at 20°C.

Effects of short-term exposure
The substance is corrosive to the eyes, the skin and the respiratory tract. Corrosive on ingestion. Inhalation of the vapour at high level may cause lung oedema (see Notes). The effects may be delayed. Medical observation is indicated.


PHYSICAL PROPERTIES ENVIRONMENTAL DATA
Boiling point: 106°C
Melting point: -7°C
Relative density (water = 1): 0.86
Solubility in water: miscible
Vapour pressure, kPa at 29.2°C: 5.3
Relative vapour density (air = 1): 3.0
Relative density of the vapour/air-mixture at 20°C (air = 1): 1.10
Flash point: 16°C c.c.
Octanol/water partition coefficient as log Pow: 0.84
 

NOTES
The symptoms of lung oedema often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation is therefore essential.
Immediate administration of an appropriate inhalation therapy by a doctor or a person authorized by him/her, should be considered.

IPCS
International
Programme on
Chemical Safety
WHO ILO UNEP EC Prepared in the context of cooperation between the International Programme on Chemical Safety and the European Commission
© IPCS 2003
LEGAL NOTICE Neither the EC nor the IPCS nor any person acting on behalf of the EC or the IPCS is responsible for the use which might be made of this information.

Top of page (Ctrl-Home) Updated by AS. Approved by EC. Last update: 23.01.2004